2025年10月30日,国家基本医保目录谈判与商保创新药目录价格协商在北京全国人大会议中心正式拉开帷幕,为期四天。上午,石药集团、绿叶制药、阿斯利康、科伦药业等十余家企业参与了谈判,其产品主要集中在抗感染、抗病毒、麻醉、镇定等普药领域。下午,辉瑞、科伦药业、勃林格殷格翰、费森尤斯卡比等多家国内外企业陆续进场,涉及的药品同样以抗感染类为主。现场一家企业领导对同行人员特别强调,报价务必慎重。这一细节...
Source Link2025年10月30日,国家基本医保目录谈判与商保创新药目录价格协商在北京全国人大会议中心正式拉开帷幕,为期四天。上午,石药集团、绿叶制药、阿斯利康、科伦药业等十余家企业参与了谈判,其产品主要集中在抗感染、抗病毒、麻醉、镇定等普药领域。下午,辉瑞、科伦药业、勃林格殷格翰、费森尤斯卡比等多家国内外企业陆续进场,涉及的药品同样以抗感染类为主。现场一家企业领导对同行人员特别强调,报价务必慎重。这一细节...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.